XML 19 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit - USD ($)
Total
As Previously Reported
Restated [Member]
Class A Ordinary Shares [Member]
Class A Ordinary Shares [Member]
Restated [Member]
Class B Ordinary Shares [Member]
Class B Ordinary Shares [Member]
Restated [Member]
Redeemable Convertible Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
As Previously Reported
Redeemable Convertible Preferred Stock [Member]
Restatement Adjustment
Redeemable Class A Common Stock [Member]
Redeemable Class A Common Stock [Member]
As Previously Reported
Redeemable Class A Common Stock [Member]
Restatement Adjustment
Common Stock [Member]
Common Stock [Member]
As Previously Reported
Common Stock [Member]
Restatement Adjustment
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
As Previously Reported
Additional Paid-in Capital [Member]
Restatement Adjustment
Additional Paid-in Capital [Member]
Restated [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
As Previously Reported
Accumulated Deficit [Member]
Restated [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
As Previously Reported
Beginning Balance at Apr. 08, 2019     $ 0   $ 0   $ 0                         $ 0     $ 0    
Beginning Balance (shares) at Apr. 08, 2019         0   0                                    
Net income (Loss)   $ 419,439                                              
Ending Balance at Sep. 30, 2019   5,000,006                                              
Beginning Balance at Apr. 08, 2019     0   $ 0   $ 0                         0     0    
Beginning Balance (shares) at Apr. 08, 2019         0   0                                    
Issuance of Class B ordinary shares to Sponsor     25,000       $ 503                         24,497          
Issuance of Class B ordinary shares to Sponsor (shares)             5,013,250                                    
Sale of units in initial public offering, net of fair value of public warrants     191,422,292   $ 2,013                             192,470,859     (1,050,580)    
Sale of units in initial public offering, net of fair value of public warrants (shares)         20,125,000                                        
Offering costs     (11,254,548)                                 (11,254,548)          
Shares subject to possible redemption     (181,242,620)   $ (1,812)                             (181,240,808)          
Shares subject to possible redemption (shares)         (18,124,262)                                        
Issuance of PIPE shares (shares)             5,013,250                                    
Issuance of PIPE shares     25,000       $ 503                         24,497          
Other comprehensive income (loss)                                                
Net income (Loss)   1,147,262 6,049,878     $ (6,000,000)                                 6,049,878    
Ending Balance (shares) at Dec. 31, 2019         2,000,738   5,013,250 84,514,191     737,058     51,588,612                      
Ending Balance at Dec. 31, 2019 (139,793,000) 5,000,009 5,000,002   $ 201   $ 503 $ 186,741,000     $ 4,500,000           $ 13,383,000       $ (153,178,000)   4,999,298 $ 2,000  
Balance as of December 31 (Shares)       18,124,262 18,124,262       186,573,651 (102,059,460)   1,627,132 (890,074)   113,887,093 (62,298,481)                  
Balance as of December 31,   139,793,000             $ 186,741,000     $ 4,500,000           $ 13,383,000       $ 153,178,000     $ 2,000
Issuance of Series D convertible preferred stock, net of issuance costs of $0.1 million (shares)               4,537,700                                  
Issuance of Series D convertible preferred stock, net of issuance costs of $0.1 million               $ 31,511,000                                  
Conversion of preferred stock to common stock (shares)                     (737,058)     737,058                      
Conversion of preferred stock to common stock 4,500,000                   $ (4,500,000)           4,500,000                
Exercise of vested stock options (shares)                           226                      
Early exercise of unvested stock options                           226                      
Vesting of early exercised stock options 11,000                               11,000                
Stock-based compensation 1,404,000                               1,404,000                
Forfeiture of unvested early exercised shares                           (46,242)                      
Expiration of the Class A common stock redemption right (shares)                     (737,058)     737,058                      
Expiration of the Class A common stock redemption right 4,500,000                   $ (4,500,000)           4,500,000                
Other comprehensive income (loss) (42,000)                                             (42,000)  
Net income (Loss) (6,033,000) 1,334,022   $ (4,823,000)                                 (6,033,000)        
Ending Balance (shares) at Mar. 31, 2020               89,051,891     0     52,279,880                      
Ending Balance at Mar. 31, 2020 (139,953,000) 5,000,001           $ 218,252,000     $ 0     $ 0     19,298,000       (159,211,000)     (40,000)  
Beginning Balance at Dec. 31, 2019 (139,793,000) 5,000,009 5,000,002   $ 201   $ 503 $ 186,741,000     $ 4,500,000           13,383,000       (153,178,000)   4,999,298 2,000  
Beginning Balance (shares) at Dec. 31, 2019         2,000,738   5,013,250 84,514,191     737,058     51,588,612                      
Net income (Loss)   1,247,246                                              
Ending Balance at Jun. 30, 2020   5,000,005                                              
Beginning Balance at Dec. 31, 2019 (139,793,000) 5,000,009 5,000,002   $ 201   $ 503 $ 186,741,000     $ 4,500,000           13,383,000       (153,178,000)   4,999,298 2,000  
Beginning Balance (shares) at Dec. 31, 2019         2,000,738   5,013,250 84,514,191     737,058     51,588,612                      
Net income (Loss)   (1,009,526)                                              
Ending Balance at Sep. 30, 2020   5,000,003                                              
Beginning Balance at Dec. 31, 2019 (139,793,000) 5,000,009 5,000,002   $ 201   $ 503 $ 186,741,000     $ 4,500,000           13,383,000       (153,178,000)   4,999,298 2,000  
Beginning Balance (shares) at Dec. 31, 2019         2,000,738   5,013,250 84,514,191     737,058     51,588,612                      
Shares subject to possible redemption     40,270,930   $ 403                             40,270,527          
Shares subject to possible redemption (shares)         4,027,093                                        
Other comprehensive income (loss)                                                
Net income (Loss)   (3,049,014) (40,270,931)     $ (40,300,000)                                 (40,270,931)    
Ending Balance (shares) at Dec. 31, 2020         6,027,831   5,013,250 93,328,118     0     52,967,106                      
Ending Balance at Dec. 31, 2020 (146,874,000) 5,000,005 5,000,001   $ 604   $ 503 $ 249,962,000     $ 0     $ 5,000     24,424,000     40,270,527 (171,292,000)   (35,271,633) (11,000)  
Beginning Balance at Mar. 31, 2020 $ (139,953,000) 5,000,001           $ 218,252,000     $ 0     $ 0     19,298,000       (159,211,000)     (40,000)  
Beginning Balance (shares) at Mar. 31, 2020               89,051,891     0     52,279,880                      
Net income (Loss)   (86,776)                                              
Ending Balance at Jun. 30, 2020   5,000,005                                              
Net income (Loss)   (2,256,772)                                              
Ending Balance at Sep. 30, 2020   5,000,003                                              
Balance as of December 31 (Shares) 93,328,118     14,097,169 14,097,169       206,031,290 (112,703,172)         116,930,602 (63,963,496)                  
Balance as of December 31, $ 249,962,000 146,874,000             $ 249,962,000             $ 5,000   $ 24,429,000 $ 5,000     $ 171,292,000     $ 11,000
Beginning Balance at Dec. 31, 2020 (146,874,000) $ 5,000,005 $ 5,000,001   $ 604   $ 503 $ 249,962,000     $ 0     $ 5,000     24,424,000     $ 40,270,527 (171,292,000)   $ (35,271,633) (11,000)  
Beginning Balance (shares) at Dec. 31, 2020         6,027,831   5,013,250 93,328,118     0     52,967,106                      
Issuance of Class B ordinary shares to Sponsor 75,000,000                         $ 1,000     74,999,000                
Issuance of Class B ordinary shares to Sponsor (shares)                           7,500,000                      
Pre-closing stock repurchase, net of exercise of vested options (shares)               (206,511)           (1,817,519)                      
Pre-closing stock repurchase, net of exercise of vested options (21,902,000)             $ (125,000)                 (21,902,000)                
Conversion of preferred stock to common stock (shares)               (93,121,607)           93,121,607                      
Conversion of preferred stock to common stock 249,837,000             $ (249,837,000)           $ 9,000     249,828,000                
Repayment of related-party promissory notes associated with vested shares 854,000                               854,000                
Forfeiture of related-party promissory notes                           (370,734)                      
Conversion of Series D preferred stock warrants to Class A common warrants 1,160,000                               1,160,000                
Exercise of Class A common stock warrants (shares)                           1,867,292                      
Exercise of Class A common stock warrants 21,678,000                               21,678,000                
Issuance of common stock upon Merger, net of transaction costs and Merger warrants liability (shares)                           23,892,244                      
Issuance of common stock upon Merger, net of transaction costs and Merger warrants liability 129,659,000                         $ 2,000     129,657,000                
Issuance of PIPE shares (shares)                           7,500,000                      
Issuance of PIPE shares 75,000,000                         $ 1,000     74,999,000                
Issuance of earn-out shares to common stockholders (shares)                           14,153,520                      
Issuance of earn-out shares to common stockholders 1,000                         $ 1,000                      
Exercise of vested stock options 80,000                               80,000                
Exercise of vested stock options (shares)                           37,887                      
Vesting of early exercised stock options 54,000                               54,000                
Warrant expense in connection with Merger 154,000                               154,000                
Stock-based compensation 34,230,000                               34,230,000                
Expiration of the Class A common stock redemption right (shares)               (93,121,607)           93,121,607                      
Expiration of the Class A common stock redemption right 249,837,000             $ (249,837,000)           $ 9,000     249,828,000                
Other comprehensive income (loss) (61,000)                                             (61,000)  
Net income (Loss) (51,404,000)     $ (49,185,000)                                 (51,404,000)        
Ending Balance (shares) at Mar. 31, 2021               0     0     191,351,403                      
Ending Balance at Mar. 31, 2021 $ 292,466,000             $ 0     $ 0     $ 18,000     $ 515,216,000       $ (222,696,000)     $ (72,000)  
Balance as of December 31 (Shares) 0                                                
Balance as of December 31, $ 0